Varicella (chickenpox) is a mild, ihighly communicable disease caused by initial exposure to varicella zoster virus (VZV). After the patient recovers VZV persists in a latent form, and when reactivated, may cause zoster, characterised by a painful vesicular eruption limited to one or more segmented dermatomes.1 Varicella and zoster can cause severe complications in cases with malignant disease or those who are immunocompromised.2 It is, therefore, important to have a highly sensitive method for accurately detecting both primary and reactivated VZV infections.
Use of either immunofluorescent or immunoperoxidase techniques for detection of specific IgG antibodies to VZV-induced membrane antigen has been found valuable in determination of immune status, and in serodiagnosis of varicella and zoster infection when paired sera taken during acute and convalescent stages of the disease are examined.3-5 A highly sensitive radioimmunoassay (RIA) and an enzyme-linked immunosorbent assay (ELISA) for detection of specific VZV IgG antibodies have been also developed recently in a number of laboratories.6-9 As far as VZV-specific IgM is concerned, it has become apparent that it is produced regularly in varicella patients, but has been detected only in some zoster patients.7 [10] [11] [12] The purpose of this study was to develop an Accepted for publication 16 November 1981 immunoperoxidase assay for the detection of VZVspecific IgA antibodies and to evaluate the feasibility of this approach for serodiagnosis of both primary and reactivated VZV infection. The specificity of the method was tested with regard to cross-reactivity with other herpes group viruses. Paired sera of five patients with clinical and serological diagnosis of acute HSV infection, five patients with CMV mononucleosis and two patients with EBV infection were found to be VZV IgA negative (<2).
VARICELLA AND ZOSTER PATIENTS
Sera from five varicella and seven zoster patients were tested for VZV-IgG and IgA antibodies by the immunoperoxidase technique. For all the patients VZV-specific IgA was detected in one or more serum samples (Table) . In sera of three patients with varicella (1, 2, 5) and two patients with zoster (9, 10) infection, peroxidase staining was observed in the nuclei of VZV-infected human embryo fibroblasts while membrane staining was observed in the other samples. In three of the varicella patients (2, 3, 5) IgA antibodies began to decline one month after the onset of the disease. Decrease of VZV IgA titre was seen 45 days after onset of rash in two of the zoster patients (10, 12) . In one patient (6) a single serum sample was available after one year. This sample was still slightly positive for VZV-specificIgA.
CONTROL-HEALTHY ADULTS
Forty-four medical students seropositive for VZVspecific IgG (and one seronegative) were tested for VZV-specific IgA antibodies and were found negative (< 2 might be detected at titres lower than two in control sera needs to be examined.
Discussion
In the present study we have developed a simple immunoperoxidase assay for detection of specific IgA to VZV. VZV IgA antibodies were detected in all varicella and zoster patients but not in any ( < 2) of the control sera from 44 healthy individuals seropositive for VZV. Neither was VZV IgA detected (< 2) in paired sera of patients with HSV, CMV or EBV infections. The possibility that VZVIgA antibodies can be detected in serum of healthy persons by a highly sensitive radioimmunoassay technique recently developed in this laboratory6 17 is being investigated. Brunnel 
